Coordinating Centre
At the pinnacle of the Network, The 3CTN Coordinating Centre acts as the leadership and communication hub for the Network and is responsible for supporting and coordinating activities at the Network sites, in order to reach the Network’s goals and objectives.
Janet Dancey, MD
Scientific Director
Bernie Eigl, MD
Associate Scientific Director
Gerald Batist, MD
Associate Scientific Director
Stephen Sundquist
Executive Director
Lam Pho
Director, Information Technology
Diana Kato
Manager, Operations
Rebecca Xu
Manager, Portfolio and Informatics
James Schoales
Portfolio Data Analyst
Raisa Chowdhury
Project Coordinator
Our Governance
Each committee in our governance brings expert knowledge at a high level, which is crucial to the success of 3CTN as it provides a link to the broader Canadian cancer research environment with the aim of maintaining 3CTN’s relevance and sustainability.
Scientific Advisory Board
David Cameron, MD (Chair)
Chair, Breast International Group
Gavin Stuart, MD
Professor, Division of Gynecologic Oncology, University of British Columbia
Judy Needham
Patient Representative
Rachel Syme, Ph.D
Assistant Director, Institute of Cancer Research, Canadian Institutes of Health Research
Stephen Sundquist
Executive Director, 3CTN
Janet Dancey, MD
Scientific Director, 3CTN
Funders Oversight Committee
Sara Urowitz (Chair)
Executive Director, Canadian Cancer Research Alliance
Christy Holtby
Vice President, Philanthropy, Alberta Cancer Foundation
Liam Kelly
Regional Director of Research and Innovation, Eastern Regional Health Authority
Lynette Hillier
Executive Director, Dr. H. Bliss Murphy Cancer Care Foundation
Gerald Batist, MD
Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)
Bernie Eigl, MD
Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency
Antonia Palmer
Patient Representative
Christine Williams, PhD
Deputy Director and Head, Clinical Translation, Ontario Institute for Cancer Research
Janet Dancey, MD
Scientific Director, 3CTN
Stephen Sundquist
Executive Director, 3CTN
Joseph Pater, MSc, MD
Emeritus Professor, Queen’s University
Management and Executive (*) Committee
Joseph Pater, MSc, MD (Chair)
Emeritus Professor, Queen’s University
Bernie Eigl*, MD
Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency
Rosalyn Juergens, MD, Ph.D
Head of the Department of Clinical Trials, Juravinski Cancer Centre
Gerald Batist*, MD
Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)
Joel Gingerich, MD
Medical Director, Community Oncology, CancerCare Manitoba
John Thoms, MD
Physician Director, Clinical Trials, Dr. H. Bliss Murphy Cancer Centre
Rosalyn Juergens, MD, Ph.D
Head of the Department of Clinical Trials, Juravinski Cancer Centre
Jim Pankovich
Vice President, Clinical Operations & Drug Development, Qu Biologics
Patricia Tang, MD
Clinical Assistant Professor, Department of Oncology, Tom Baker Cancer Centre
Jim Whitlock, MD
Division Head, Haematology/Oncology, The Hospital for Sick Children
Chantale Thurston
Patient Representative
Don Wood
Patient Representative
Lam Pho
Director, Information Technology, 3CTN
Janet Dancey*, MD
Scientific Director, 3CTN
Stephen Sundquist
Executive Director, 3CTN
Our Operating/Advisory Committees
Portfolio Sub-Committee
This team is responsible for reviewing the criteria for trial entry into the Portfolio and metrics for trial retention within the Portfolio; and reviewing the trial Portfolio for scientific merit, priority, performance and strategic balance to cover the range of trials of interest/relevance to Canadians and the Canadian health care system.
Joseph Pater, MSc, MD (Chair)
Emeritus Professor, Queen’s University
Jim Wright, MD
Radiation Oncologist, Juravinski Cancer Centre
Janet Dancey, MD
Scientific Director, 3CTN
Stephen Sundquist
Executive Director
Rebecca Xu
Manager, Portfolio and Informatics
James Schoales
Portfolio Data Analyst
Performance Strategy Sub-Committee
This team is responsible for evaluating Network performance, identifying problems and proposing new initiatives, tools to improve the efficiency and quality of trial activities, improvements to and competencies of clinical trial staff through education, training and mentoring and greater patient access to trials.
Brenda Kowaleski (Chair)
Clinical Trials Manager, Juravinski Cancer Centre
Lynn Dwernychuk
Director, Clinical Research, Saskatchewan Cancer Agency
Dora Nomikos
Manager, Trial Management Group, Canadian Cancer Trials Group
Carla Girolametto
Director, Innovation and Research and Clinical Trials, Grand River Hospital
Christine Samara
Manager, Quality Assurance and Education, Odette Cancer Centre Clinical Research Program
Stephen Sundquist
Executive Director, 3CTN
Patient Representative Advisory Sub-Committee
The PRAC is a team of 3CTN Patient Representatives and 3CTN CC staff with the focus of providing feedback, insight, expertise and support to the Network.
Don Wood (Chair)
Alberta
Gretta Hutton
Ontario
Louise Gagne
Quebec
Jean-Francois Denault
Quebec
Stephanie Mayne
Newfoundland
Alison Stoneman
Ontario
Emily Piercell
Ontario
Amy Clark
Manitoba
Stephen Sundquist
Executive Director, 3CTN